logo
Select company
Select metric
88.34%Gross Profits to Assets
VS
Market
98
Sector
97
Industry
98
History
90
$ 5.45Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information

Ticker

PBYI

Company Name

PUMA BIOTECHNOLOGY INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PUMA BIOTECHNOLOGY INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PBYI - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 194.92M$ 172.19M88.34%
3/31/2025$ 196.18M$ 168.48M85.88%
12/31/2024$ 213.33M$ 166.06M77.84%
9/30/2024$ 220.72M$ 168.76M76.46%
6/30/2024$ 205M$ 160.15M78.12%
3/31/2024$ 214.15M$ 166.44M77.72%
12/31/2023$ 230.53M$ 172.96M75.03%
9/30/2023$ 203.6M$ 173.94M85.43%
6/30/2023$ 200.49M$ 175.71M87.64%
3/31/2023$ 196.26M$ 177.6M90.5%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) GPA stands at 75.24%.
  • Over the past 5 years, PUMA BIOTECHNOLOGY INC's average GPA has been 80.93%.
  • The median GPA for PUMA BIOTECHNOLOGY INC during this period was 80.08%
  • PUMA BIOTECHNOLOGY INC reached its highest GPA over the past 5 years at 90.5%.
  • The lowest GPA recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 74.02%

PUMA BIOTECHNOLOGY INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
HRTX : HERON THERAPEUTICS INC 48.13%VNDA : VANDA PHARMACEUTICALS INC 30.74%MGNX : MACROGENICS INC 58.61%ENTA : ENANTA PHARMACEUTICALS INC 21.53%AGEN : AGENUS INC 54.56%ALEC : ALECTOR INC 22.76%ATRA : ATARA BIOTHERAPEUTICS INC 415.36%SGMO : SANGAMO THERAPEUTICS INC 83.75%CHRS : COHERUS ONCOLOGY INC 18.69%GLUE : MONTE ROSA THERAPEUTICS INC 49.5%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for PUMA BIOTECHNOLOGY INC is calculated as follows: GP [ $ 196.9M ] / Assets [ $ 261.69M ]
(=) GPA [ 75.24% ]

PBYI - Gross Profits to Assets, Last 5 years

74.02%

Minimum

Jun 30, 2021

90.5%

Maximum

Mar 31, 2023

80.93%

Average

80.08%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.15% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.14K
min-50.32%
max83.98%
average20.15%
median15.34%
std19.95%